TY - JOUR
T1 - Histamine H2-receptor mediated activation of neonatal rat brain ornithine decarboxylase in vivo
AU - Rodriguez, Jose
AU - Toledo, Alfonso
AU - Brandner, Regina
AU - Rodriguez, Ricardo
AU - Sabria, Josefa
AU - Blanco, Isaac
PY - 1988/2/1
Y1 - 1988/2/1
N2 - The effect of histamine (HA) administered via intracerebroventricular injection on ornithine decarboxylase (ODC) activity was studied in neonatal rat brain. The HA effect was dose and time dependent. Maximal increase in ODC activity was achieved 2 hr after administration of 10 μg HA (38% over control levels). Impromidine (HA H2-agonist) mimicked the effect of HA on ODC and ranitidine (HA H2-antagonist) inhibited the response to HA. Neither 2-thiazolylethylamine (HA H1-agonist) nor mepyramine (HA H1-antagonist) modified control ODC activity. The HA-releasers, compound 48/80 and polymixin B sulfate, elicited an increase in brain ODC activity of 35% and 32%, respectively, over the control value. © 1988.
AB - The effect of histamine (HA) administered via intracerebroventricular injection on ornithine decarboxylase (ODC) activity was studied in neonatal rat brain. The HA effect was dose and time dependent. Maximal increase in ODC activity was achieved 2 hr after administration of 10 μg HA (38% over control levels). Impromidine (HA H2-agonist) mimicked the effect of HA on ODC and ranitidine (HA H2-antagonist) inhibited the response to HA. Neither 2-thiazolylethylamine (HA H1-agonist) nor mepyramine (HA H1-antagonist) modified control ODC activity. The HA-releasers, compound 48/80 and polymixin B sulfate, elicited an increase in brain ODC activity of 35% and 32%, respectively, over the control value. © 1988.
U2 - https://doi.org/10.1016/0006-2952(88)90228-6
DO - https://doi.org/10.1016/0006-2952(88)90228-6
M3 - Article
SN - 0006-2952
VL - 37
SP - 551
EP - 554
JO - Biochemical Pharmacology
JF - Biochemical Pharmacology
ER -